Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Westphal Christoph H
Relationship:   10% Owner
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   6,222,903    

Indirect Shares

   9,212,891      
Direct Value   $5,756,496    

Indirect Value

   $376,567,668      
Total Shares   15,435,794      
Total Value   $382,324,164      


Verastem, Inc. $2,620,983 Tempest Therapeutics, Inc $744,043 Salarius Pharmaceuticals, Inc $2,391,470 Tscan Therapeutics, Inc. $0 Verastem, Inc. $2,620,983 Tempest Therapeutics, Inc $744,043 Salarius Pharmaceuticals, Inc $2,391,470 Tscan Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA Director 2004-06-25 0 2004-06-25 76,648    Premium*  
            Alnylam Pharmaceuticals Inc ALNY Director, 10% Owner 2004-05-27 0 2004-06-03 2,409,970    Premium*  
            Verastem, Inc. VSTM Executive Chairman, Di... 2015-06-30 665,224 2015-06-30 1,500,063    Premium*  
            Tempest Therapeutics, Inc TPST Director, 10% Owner 2014-03-07 701,927 2014-03-07 3,825,421    Premium*  
            Salarius Pharmaceuticals, Inc SLRX 10% Owner 2018-10-16 3,941,118 2018-10-16 0    Premium*  
            Tscan Therapeutics, Inc. TCRX 10% Owner 2021-07-20 914,634 2021-07-20 1,400,789    Premium*  
* Premium Members only  

Records found :    137         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VSTM Verastem, Inc. Chief Executive Officer   •       •       •   2013-01-18 4 A $9.97 $7,995 D/D 800 712,069 0 -
VSTM Verastem, Inc. Director   –       •       •   2013-10-31 4 A $9.99 $7,996 D/D 800 695,872 0 -
VSTM Verastem, Inc. President and CEO   •       •       •   2012-02-01 4 A $10.00 $6,000,000 I/I 600,000 2,869,841 0 -
VSTM Verastem, Inc. Chief Executive Officer   •       •       •   2013-01-29 4 AB $10.00 $3,000 D/D 300 712,369 0 -
TPST Tempest Therapeutics, Inc Director   –       •       •   2014-03-07 4 B $10.00 $1,000,000 I/I 100,000 3,820,571 2.25 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-13 4 B $10.09 $73,344 I/I 7,269 3,028,113 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-10 4 B $10.14 $127,531 I/I 12,577 2,990,627 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-11 4 B $10.33 $145,860 I/I 14,120 3,004,747 2.64 -
VSTM Verastem, Inc. Executive Chairman   •       •      –    2014-03-31 4 D $10.36 $57,498 D/D (5,550) 698,264 0 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-16 4 B $10.40 $85,280 I/I 8,200 3,036,313 2.64 -
VSTM Verastem, Inc. Executive Chairman   •       •      –    2015-03-31 4 D $10.49 $29,550 D/D (2,817) 674,328 0 -
TPST Tempest Therapeutics, Inc Director   –       •       •   2013-09-11 4 B $10.53 $51,071 I/I 4,850 4,850 2.25 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2015-10-26 4 AB $10.55 $11,003 D/D 1,043 3,918,588 0 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-24 4 B $10.55 $255,384 I/I 24,207 2,960,518 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2015-10-19 4 AB $10.61 $10,797 D/D 1,018 3,917,545 0 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2015-11-16 4 AB $10.78 $10,791 D/D 1,001 3,921,556 0 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-16 4 B $10.85 $207,691 I/I 19,142 2,825,323 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-17 4 B $10.94 $209,359 I/I 19,137 2,844,460 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-17 4 B $10.98 $32,940 I/I 3,000 3,201,461 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-19 4 B $11.00 $76,054 I/I 6,914 3,076,627 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2015-11-09 4 AB $11.03 $11,032 D/D 1,000 3,920,555 0 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-22 4 B $11.03 $31,987 I/I 2,900 3,210,161 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-18 4 B $11.05 $167,960 I/I 15,200 3,069,713 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-18 4 B $11.06 $203,913 I/I 18,437 2,862,897 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-21 4 B $11.07 $30,996 I/I 2,800 3,207,261 2.64 -
  137  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us